UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934

ofDate ~~the~~of ~~Securities~~Report ~~Exchange~~(Date ~~Act~~ of ~~1934~~earliest event reported): March 28th, 2019

~~Date~~Nexeon ~~of Report (Date of earliest event reported): December 11~~Medsystems, ~~2018~~Inc.

Nexeon Medsystems Inc

(Exact name of registrant as specified in its charter)

Nevada		000-55655		81-0756622
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1910 Pacific Avenue, Suite 20000 Dallas, Texas 75201 (Address of principal executive offices) (zip code) 844-919-9990 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report.)

1910 Pacific Avenue, Suite 20000

Dallas, Texas

75201

(Address of principal executive offices)

(Zip Code)

~~Check the appropriate box below if the Form 8~~844-K919-9990 ~~filing~~(Registrant’s istelephone ~~intended~~number, toincluding ~~simultaneously~~area ~~satisfy~~code) ~~the~~Not ~~filing~~applicable ~~obligation~~(Former ofname ~~the~~or ~~registrant under~~former ~~any~~address, ofif ~~the~~changed ~~following~~since ~~provisions:~~last report.)

☐Check the ~~Written~~appropriate ~~communications~~box ~~pursuant~~below toif ~~Rule 425 under~~ the ~~Securities~~Form ~~Act~~8-K ~~(17~~filing ~~CFR~~is ~~230.425)~~intended ~~☐ Soliciting material pursuant~~ to ~~Rule~~simultaneously ~~14a-12~~satisfy ~~under~~ the ~~Exchange~~filing ~~Act~~obligation ~~(17~~of ~~CFR~~the ~~240.14a-12)~~registrant under ☐any ~~Pre-commencement~~of ~~communications pursuant to Rule 14d-2(b) under~~ the ~~Exchange~~following ~~Act~~provisions (17see ~~CFR~~General ~~240~~Instruction A.~~14d-~~2~~(b))~~. ~~☐ Pre-commencement communications pursuant to Rule 13e-4(c~~below) ~~under the Exchange Act (17 CFR 240.13e-4(c))~~:

~~Indicate by~~☐ ~~check~~Written ~~mark~~communications ~~whether~~pursuant ~~the~~to ~~registrant is an emerging growth company as defined in~~ Rule ~~405~~425 ofunder the Securities Act of(17 ~~1933~~CFR (§230.~~405 of this chapter~~425) ~~or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).~~

~~Emerging growth~~☐ ~~company~~Soliciting ☒material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7 5.0102 ~~Regulation~~Departure FDof ~~Disclosure~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~Nexeon~~On ~~Medsystems~~March ~~Inc~~28, ~~(the~~2019, ~~“Company”)~~Wes ~~has~~Ditmer ~~made~~resigned ~~available~~from anhis ~~updated~~position ~~presentation~~as ~~about~~a ~~its~~member ~~business,~~of athe ~~copy~~Board of ~~which~~Directors isof ~~filed~~Nexeon Medsystems Inc (the “Company”) aseffective ~~Exhibit~~immediately. 99Mr.1 toDitmer’s ~~this~~resignation ~~Current~~did ~~Report~~not onresult ~~Form~~from ~~8-K~~any (disagreement with the ~~“Report”)~~Company ~~and~~on isany ~~hereby~~matter ~~incorporated~~relating to byits ~~reference~~operations, policies or practices.

~~The~~Cautionary ~~information~~Note ~~contained~~Regarding inForward-Looking the presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission and other public announcements the Company may make by press release or otherwise from time to time. The presentation speaks as of the date of this Report. While the Company may elect to update the presentation in the future to reflect events and circumstances occurring or existing after the date of this Report, the Company specifically disclaims any obligation to do so.Statements

~~The~~This ~~presentation~~current report on Form 8-K contains “forward-looking statements,” ~~and~~within asthe ameaning ~~result,~~of ~~investors~~the ~~should~~safe ~~not~~harbor ~~place~~provisions of ~~undue~~the ~~reliance~~U.S. onPrivate ~~these~~Securities ~~forward-looking statements~~Litigation Reform Act of 1995.

~~The~~Forward-looking ~~information~~statements ~~set~~can ~~forth~~be inidentified ~~this~~by ~~Report~~words such as: “anticipate,” ~~including~~“intend,” ~~without~~“plan,” ~~limitation~~“goal,” “seek,” ~~the~~“aim,” ~~presentation~~“strive,” is“believe,” ~~not~~“project,” ~~deemed~~“predict,” “estimate,” “~~filed~~expect,” ~~for~~“continue,” ~~purposes~~“strategy,” “future,” “likely,” of“may,” ~~Section~~“might,” 18“should,” of“will,” the ~~Securities~~negative ~~Exchange~~of ~~Act~~these terms, and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of ~~1934~~future performance. Instead, asthey are ~~amended~~based (only on our current beliefs, expectations and assumptions regarding the ~~“Exchange~~future ~~Act”)~~of our business, orfuture ~~incorporated~~plans byand ~~reference~~strategies, inprojections, ~~any~~anticipated ~~filing~~events ~~under~~and trends, the ~~Securities~~economy ~~Act~~and ofother ~~1933~~future conditions. Because forward-looking statements relate to the future, asthey ~~amended~~are subject to inherent uncertainties, orrisks and changes in circumstances that are difficult to predict and many of which are outside of our control. A detailed discussion of some of the ~~Exchange~~risks ~~Act,~~and ~~except~~uncertainties asthat ~~may~~could because ~~expressly~~our ~~set~~actual results ~~forth~~and byfinancial ~~specific~~condition to differ materially from the forward-looking statements is described under the caption “Risk ~~reference~~Factors” in ~~such~~our amost ~~filing~~recent annual report on Form 10-K, along with our other filings with the SEC.

~~Item~~Any ~~9.01~~forward-looking ~~Financial~~statement ~~Statements~~made by us in this current report on Form 8-K is based only on information currently available to us and ~~Exhibits~~speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

(d) Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

Exhibit No.		Description
99.1		Corporate Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.

	NEXEON MEDSYSTEMS INC
Dated: December 11, 2018	/s/ William Rosellini
	William Rosellini
	Chairman and Chief Executive Officer

/s/ Will Rosellini
Will Rosellini Chairman and CEO

Date: April 1, 2019

Filing Compare · NEXEON MEDSYSTEMS INC